抗高密度脂蛋白抗体与原发性干燥综合征不良血脂及蛋白组学特征相关
在44例干燥综合征患者和80例对照中,抗HDL和抗ApoA1 IgG水平显著升高,且与不良脂蛋白谱、促炎细胞因子及蛋白组学特征相关。抗HDL抗体可改善SCORE2风险分层,提示其可能连接自身免疫、脂代谢与心血管疾病。
要点
- 干燥综合征患者抗HDL和抗ApoA1 IgG水平显著高于对照。
- 抗HDL与不良血脂谱及促炎蛋白组学特征相关。
- 抗HDL抗体可改善SCORE2对干燥综合征的风险分层。
核心结论
- 抗HDL体液免疫应答是干燥综合征的特征,可能与自身免疫、脂代谢异常和心血管疾病相关。
研究设计与样本
- 测量44例干燥综合征患者和80例对照的血清抗HDL及抗ApoA1 IgG水平,并以80例狼疮患者验证。
- 采用多普勒超声评估动脉粥样硬化,H-NMR进行脂蛋白和脂质谱分析,免疫分析检测细胞因子和载脂蛋白,高通量靶向蛋白组学检测心脏代谢相关蛋白。
主要发现
- 干燥综合征患者抗HDL和抗ApoA1 IgG水平均显著高于对照(两者P<0.010),达到与狼疮患者相当的水平且独立于传统危险因素。
- 抗HDL水平与不良脂蛋白和脂质谱、促炎细胞因子及与免疫应答和组织重塑相关的蛋白组学特征一致相关。
- 抗ApoA1水平与炎症和疾病活动度相关。
- 在干燥综合征中,抗HDL与脂质组学/蛋白组学特征的关系随动脉粥样硬化状态而变化,但抗体水平无差异。
- 抗HDL抗体而非抗ApoA1可改善SCORE2的风险分层。
临床怎么用
- 抗HDL抗体可能作为干燥综合征心血管风险分层的辅助标志物,尤其在与SCORE2联合评估时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Immune-mediated mechanisms and altered lipid metabolism may contribute to increased cardiovascular risk in Sjögren's disease (SjD). Antibodies targeting high-density lipoprotein (HDL) have emerged as modulators of lipid dysfunction and inflammation in several rheumatic diseases, but their relevance in SjD remains unexplored. We aimed to characterize humoral responses against HDL in SjD and their associations with lipoprotein/lipid traits, inflammatory and proteomic features, and atherosclerosis. METHODS: IgG serum levels of antibodies against HDL (anti-HDL) and apolipoprotein A1 (anti-ApoA1) were measured in 44 SjD patients and 80 controls. Lupus patients (n = 80) were included for validation. Atherosclerosis was evaluated by Doppler-ultrasound. Lipoprotein and lipid profiling were performed by H-NMR. Cytokines and apolipoproteins were measured by immunoassays. A cardiometabolic-related protein panel was assessed by high-throughput targeted proteomics. RESULTS: Anti-HDL and anti-ApoA1 IgG levels were significantly elevated in SjD patients compared with controls (both P < 0.010), reaching levels comparable to those observed in lupus and independently of traditional risk factors. Anti-HDL levels were consistently associated with unfavourable lipoprotein and lipid profiles, proinflammatory cytokines and proteomic signatures linked to immune responses and tissue remodelling. In contrast, anti-ApoA1 levels were correlated with inflammation and disease activity. In SjD, the relationships between anti-HDL and lipidomic/proteomic features varied according to atherosclerosis status, although antibody levels did not differ. Anti-HDL antibodies, but not anti-ApoA1, improved risk stratification over SCORE2. CONCLUSIONS: Humoral responses against HDL particles hallmark SjD, with different trajectories observed for functional and clinical correlates, probably linked to altered lipoprotein composition. Anti-HDL could be a missing link between autoimmunity, lipid metabolism and cardiovascular disease.
引用
- Suárez-Díaz S, Miranda-Prieto D, López P, et al. Humoral responses against high-density lipoprotein are linked to unfavourable lipid and proteomic signatures in primary Sjögren's disease-a multi-platform approach. Rheumatology (Oxford). 2026. PMID: 41910589. doi:10.1093/rheumatology/keag141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。